Results 161 to 170 of about 309,698 (208)

Hs-CRP, Diabetic Status, and Adverse Events Among Patients Receiving Statin Therapy Following PCI-A Prospective Registry-Based Study. [PDF]

J Inflamm Res
Chen X, Wang HY, Sun W, Lin Z, Qiao Z, Bian X, Yin D, Feng L, Zhu C, Song W, Wang H, Jia L, Dong Q, Dou K.   +13 more
europepmc   +1 more source

A nomogram for predicting malnutrition risk in patients with chronic heart failure and correlation study between GHRL, MSTN, CRP, Hs-CRP. [PDF]

BMC Cardiovasc Disord
Zha Y, Liu C, Zhou Y, Kong M, Liu J, Jing L, Gulimila H.   +6 more
europepmc   +1 more source

Altered Anthropometrics and HbA1c Levels, but not Dyslipidemia, Are Associated With Elevated hs-CRP Levels in Middle-aged Adults: A Population-based Analysis. [PDF]

Crit Pathw Cardiol
Ashour L, Ayesh L, Jarrar Z, Mishleb A, Alenezi D, Fateh M, Almejaibal R, Hanna Madani N, Mohammad Dabas M, Abu Monshar SS, Hamdan S.   +10 more
europepmc   +1 more source

The association between the hs-CRP/HDL-C ratio and nonalcoholic fatty liver disease: The mediating role of insulin resistance in a cross-sectional study using NHANES 2017-2020. [PDF]

Medicine (Baltimore)
Zhang FM, Zhao HD, Qi ZM, Chen R, Liao ZX, Xie LF, Zheng C.   +6 more
europepmc   +1 more source

Comparative Analysis of Biomarkers in CAD: Evaluating Homocysteine, Lipid HS-CRP, Apo A, and ADMA. [PDF]

J Pharm Bioallied Sci
Singh SK, Jha RK, Ambad RS, Jha RK.
europepmc   +1 more source

Changes in the Level of hs-CRP in the Blood and Morphometric Parameters of Tissues Following Implantation of Polypropylene. [PDF]

Int J Mol Sci
Eisenach IA, Lapii GA, Uzyumova AK, Lushnikova EL, Ovchinnikov VS, Solovieva AO, Oorzhak OV, Kuznetsov AV.   +7 more
europepmc   +1 more source

Baseline hs‐CRP predicts hypertension remission in metabolic syndrome

European Journal of Clinical Investigation, 2019
AbstractBackgroundInflammation, overweight and other cardiovascular risk factors might negatively impact on hypertension remission in metabolic syndrome (MetS), independently of the pharmacological treatment. Here, the potential influence of systemic inflammation (assessed by serum high‐sensitivity C‐reactive protein [hs‐CRP]) on hypertension remission
Carbone, F, Elia, E, Casula, M, Bonaventura, A, Liberale, L, Bertolotto, M, Artom, N, Minetti, S, Dallegri, F, Contini, P, Verzola, D, Pontremoli, R, Viazzi, F, L Viviani, G, Bertolini, S, Pende, A, Pisciotta, L, Montecucco, F   +17 more
openaire   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Hs-CRP in stroke: A meta-analysis

Clinica Chimica Acta, 2016
Studies on high-sensitivity C-reactive protein (hs-CRP) and stroke risk have yielded conflicting results.To determine whether elevated baseline hs-CRP presents an independent risk for different kinds of strokes by conducting a meta-analysis.The PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure and Wanfang databases were ...
Yongjing, Zhou, Wei, Han, Dandan, Gong, Changfeng, Man, Yu, Fan   +4 more
openaire   +2 more sources

Hs-CRP in early childhood wheezing

7.2 Paediatric Asthma and Allergy, 2016
Introduction: High-sensitivity C -reactive protein (hs-CRP) is a biomarker reflecting low-grade systemic inflammation, but its role among wheezing infants is still unknown. Objective: To demonstrate, whether hs-CRP has any association with recurrent wheezing, atopic markers, baseline lung function, or airway responsiveness in infants with ...
Määttä, Anette, Kotaniemi-Syrjänen, Anne, Malmström, Kristiina, L. Pekka Malmberg, Pelkonen, Anna S., Mäkelä, Mika J.   +5 more
openaire   +1 more source